These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37291016)

  • 1. Ventricular arrhythmias and cardiac arrest in atrial fibrillation patients with pacemakers and implantable cardioverter-defibrillators.
    Fawzy AM; Bisson A; Bentounes SA; Bodin A; Herbert J; Lip GYH; Fauchier L
    Eur J Intern Med; 2023 Sep; 115():70-78. PubMed ID: 37291016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of ventricular tachyarrhythmia in patients with implantable cardioverter-defibrillator and non-ischemic systolic heart failure.
    Jędrzejczyk-Patej E; Mazurek M; Lazar M; Pruszkowska-Skrzep P; Sokal A; Kowalczyk J; Kowalski O; Kalarus Z; Lenarczyk R
    Kardiol Pol; 2023; 81(10):998-1005. PubMed ID: 37936556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in amiodarone efficacy in relation to ejection fraction and basal rhythm in patients with implantable cardioverter defibrillators.
    Watanabe T; Inoue K; Kashiwase K; Mine T; Hirooka K; Shutta R; Mizuno H; Okuyama Y; Sakata Y; Nanto S;
    J Electrocardiol; 2018; 51(6):1111-1115. PubMed ID: 30497740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-Based Differences in Selected Cardiac Implantable Electronic Device Use: A 10-Year Statewide Patient Cohort.
    De Silva K; Nassar N; Badgery-Parker T; Kumar S; Taylor L; Kovoor P; Zaman S; Wilson A; Chow CK
    J Am Heart Assoc; 2022 Aug; 11(16):e025428. PubMed ID: 35943057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of device detected atrial and ventricular tachyarrhythmia with adverse events in patients with an implantable cardioverter-defibrillator.
    Abbas H; Younis A; Goldenberg I; McNitt S; Aktas MK; Tabaja C; Ojo A
    J Cardiovasc Electrophysiol; 2024 Jun; 35(6):1203-1211. PubMed ID: 38606650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arrhythmic Risk in Biventricular Pacing Compared With Left Bundle Branch Area Pacing: Results From the I-CLAS Study.
    Herweg B; Sharma PS; Cano Ó; Ponnusamy SS; Zanon F; Jastrzebski M; Zou J; Chelu MG; Vernooy K; Whinnett ZI; Nair GM; Molina-Lerma M; Curila K; Zalavadia D; Dye C; Vipparthy SC; Brunetti R; Mumtaz M; Moskal P; Leong AM; van Stipdonk A; George J; Qadeer YK; Kolominsky J; Golian M; Morcos R; Marcantoni L; Subzposh FA; Ellenbogen KA; Vijayaraman P
    Circulation; 2024 Jan; 149(5):379-390. PubMed ID: 37950738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in treated ventricular fibrillation out-of-hospital cardiac arrest: a 17-year population-based study.
    Bunch TJ; White RD; Friedman PA; Kottke TE; Wu LA; Packer DL
    Heart Rhythm; 2004 Sep; 1(3):255-9. PubMed ID: 15851165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RyR2 Common Gene Variant G1886S and the Risk of Ventricular Arrhythmias in ICD Patients with Heart Failure.
    Francia P; Adduci C; Semprini L; Stanzione R; Serdoz A; Caprinozzi M; Santini D; Cotugno M; Palano F; Musumeci MB; Rubattu S; Volpe M
    J Cardiovasc Electrophysiol; 2015 Jun; 26(6):656-61. PubMed ID: 25773045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventional electrophysiology and its role in the treatment of cardiac arrhythmia.
    Teo WS; Kam R; Tan A
    Ann Acad Med Singap; 1998 Mar; 27(2):248-54. PubMed ID: 9663319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
    Klein G; Lissel C; Fuchs AC; Gardiwal A; Oswald H; Desousa M; Pichlmaier AM; Lichtinghagen R; Geerlings H; Lippolt P; Niehaus M; Drexler H; Korte T
    Europace; 2006 Aug; 8(8):618-24. PubMed ID: 16864615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic relevance of new onset arrhythmia and ICD shocks in primary prophylactic ICD patients.
    Kleemann T; Strauss M; Kouraki K; Werner N; Zahn R
    Clin Res Cardiol; 2020 Jan; 109(1):89-95. PubMed ID: 31087157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of implantable cardioverter defibrillators in non VT/VF sudden deaths.
    Thakur RK; Aufderheide TP; Tresch DD; Ghani M
    Pacing Clin Electrophysiol; 1994 Jul; 17(7):1264-6. PubMed ID: 7937232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of atrial fibrillation with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients.
    Fischer A; Ousdigian KT; Johnson JW; Gillberg JM; Wilkoff BL
    Heart Rhythm; 2012 Jan; 9(1):24-31. PubMed ID: 21835150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do atrial tachyarrhythmias beget ventricular tachyarrhythmias in defibrillator recipients?
    Stein KM; Euler DE; Mehra R; Seidl K; Slotwiner DJ; Mittal S; Markowitz SM; Lerman BB;
    J Am Coll Cardiol; 2002 Jul; 40(2):335-40. PubMed ID: 12106941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic analysis of cardiac rhythms for discriminating atrial fibrillation from lethal ventricular arrhythmias.
    DeMazumder D; Lake DE; Cheng A; Moss TJ; Guallar E; Weiss RG; Jones SR; Tomaselli GF; Moorman JR
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):555-61. PubMed ID: 23685539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appropriate implantable cardioverter-defibrillator interventions in cardiac resynchronization therapy-defibrillator (CRT-D) patients undergoing device replacement: time to downgrade from CRT-D to CRT-pacemaker? Insights from real-world clinical practice in the DECODE CRT-D analysis.
    Narducci ML; Biffi M; Ammendola E; Vado A; Campana A; Potenza DR; Iori M; Zanon F; Zacà V; Zoni Berisso M; Bertini M; Lissoni F; Bandini A; Malacrida M; Crea F
    Europace; 2018 Sep; 20(9):1475-1483. PubMed ID: 29186401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.
    Elliott PM; Sharma S; Varnava A; Poloniecki J; Rowland E; McKenna WJ
    J Am Coll Cardiol; 1999 May; 33(6):1596-601. PubMed ID: 10334430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pacemaker and implantable cardioverter-defibrillator use in a US myotonic dystrophy type 1 population.
    Bhakta D; Shen C; Kron J; Epstein AE; Pascuzzi RM; Groh WJ
    J Cardiovasc Electrophysiol; 2011 Dec; 22(12):1369-75. PubMed ID: 22035077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.
    Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL
    J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.